What is considered very high risk which requires secondary prevention?
ASCVD
What is considered very high/high risk which requires primary prevention?
Familial hypercholesterolaemia (FH), DM, CKD
What should you do if there are no very high or high risk factors?
Calculate 10 year risk score using SG-FRS
Using the SG-FRS, what risk score is considered:
- high risk
- intermediate risk
- borderline risk
- low risk
If no comorbidities and LDL-C < 4.9, what is the target LDL-C for patients of:
- high risk
- intermediate risk
- borderline risk
- low risk
If no comorbidities and LDL-C < 4.9, what is the preferred treatment for patients of:
- high risk
- intermediate risk
- borderline risk
- low risk
If ASCVD & LDL-C > 4.9, what is the target LDL-C? (different conditions)
If ASCVD & LDL-C > 4.9, what is the preferred treatment?
If FH & LDL-C > 4.9, what is the target LDL-C? (different conditions)
If DM & LDL-C > 4.9, what is the preferred treatment? (different conditions)
If CKD & LDL-C > 4.9, what is the preferred treatment?
moderate-intensity statin +- ezetimibe in non-dialysis dependent pts
If FH & LDL-C > 4.9, what is the preferred treatment?
If DM & LDL-C > 4.9, what is the target LDL-C level? (diff conditions)
If CKD & LDL-C > 4.9, what is the target LDL-C?
eGFR < 60 +/ ACR ≥3: < 2.6 mmol/L
If LDL-C > 4.9 but not FH (no other comorbidities), what is the target LDL-C?
Calculate 10y SG-FRS to determine target
If LDL-C > 4.9 but not FH (no other comorbidities), what is the preferred treatment?
at least moderate-intensity statin
How much do the following statins reduce LDL-C by:
- high-intensity statin
- moderate-intensity statin
and give examples
MOA of statins?
Inhibit HMG-CoA reductase -> inhibit cholesterol synthesis in liver -> liver takes up more LDL to be destroyed (up regulation of LDL receptor) -> reduce LDL in bloodstream
Should statins be used in pregnancy?
No (generally avoided)
Lifestyle modifications for lipid management?
Rank the potency of statins from weakest to strongest
lovastatin < simvastatin < atorvastatin < rosuvastatin
PCSK9 inhibitors MOA and examples?
MOA: inhibit PCSK9 (which breaks down LDL receptors) -> more cellular uptake of LDL from plasma
Examples: evolocumab, alirocumab
Rank the potency of lipid therapies from lowest to highest LDL lowering
ezetimibe < statin < PCSK9 inhibitor
What is considered ASCVD? (8)